Revelation Biosc -CW27REVBWPreferred / convertible
13F holders, Q4 2024 (December 31)11holders −2
0new positions
1sold out
1famous investor
$0.01avg. 13F price*
At the end of Q4 2024, 11 institutions reported holding Revelation Biosc -CW27 (REVBW) in their 13F filings, down 2 from Q3 2024. 0 opened new positions and 1 sold out. The largest holders were Linden Advisors LP ($3K), Yakira Capital Management, Inc. ($2K) and Pine Valley Investments Ltd Liability Co ($695). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Revelation Biosc -CW27
- CUSIP
- 76135L119
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $2 |
All 13F filers, Q3 2024 → Q4 2024: 41,385 shares bought and 237,056 shares sold, net −195,671 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| Linden Advisors LP | — | No change | 338,110 | $3K |
| Yakira Capital Management, Inc. | — | No change | 246,884 | $2K |
| Pine Valley Investments Ltd Liability Co | — | Reduce -30.1% | 99,290 | $695 |
| Walleye Trading LLC | — | Reduce -11.0% | 93,435 | $654 |
| Wolverine Asset Management LLC | — | Add +146.6% | 54,752 | $383 |
| Jane Street Group, LLC | — | No change | 50,000 | $350 |
| Citadel Advisors | — | Add +30.1% | 38,235 | $268 |
| Two Sigma Securities, LLC | — | Reduce -34.5% | 10,354 | $72 |
| Walleye Capital LLC | — | Reduce -94.6% | 10,074 | $71 |
| UBS Group AG | — | Reduce -5.8% | 2,512 | $18 |
| POM Investment Strategies, LLC | — | No change | 1,005 | $7 |
"% of holder's portfolio" is REVBW's weight in each manager's 13F, not the share of Revelation Biosc -CW27 the manager owns.